du Bois A - Search Results

1

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial.

Untch M, Eidtmann H, du Bois A, Meerpohl HG, Thomssen Ch, Ebert A, Harbeck N, Jackisch C, Heilman V, Emons G, Wallwiener D, Wiese W, Blohmer JU, Höffken K, Kuhn W, Reichardt P, Muscholl M, Pauschinger M, Langer B, Lück HJ. Untch M, et al. Among authors: du bois a. Eur J Cancer. 2004 May;40(7):988-97. doi: 10.1016/j.ejca.2004.01.011. Eur J Cancer. 2004. PMID: 15093573 Clinical Trial.

2

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron.

du Bois A, Meerpohl HG, Vach W, Kommoss FG, Fenzl E, Pfleiderer A. du Bois A, et al. Eur J Cancer. 1992;28(2-3):450-7. doi: 10.1016/s0959-8049(05)80075-9. Eur J Cancer. 1992. PMID: 1534250

3

[Refractory vomiting with cisplatin therapy. Prospective study with the serotonin receptor antagonist GR 38032F].

du Bois A, Meerpohl HG, Wilhelm C, Quaas L, Barnickel I, Pfleiderer A. du Bois A, et al. Onkologie. 1990 Oct;13(5):364-8. doi: 10.1159/000216797. Onkologie. 1990. PMID: 2150551 Clinical Trial. German.

4

Comparison of the emetogenic potential between cisplatin and carboplatin in combination with alkylating agents.

du Bois A, Vach W, Thomssen C, Karck U, Madjar H, Prömpeler H, Meerpohl HG. du Bois A, et al. Acta Oncol. 1994;33(5):531-5. doi: 10.3109/02841869409083931. Acta Oncol. 1994. PMID: 7917367 Clinical Trial.

5

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

6

The role of serotonin as a mediator of emesis induced by different stimuli.

du Bois A, Kriesinger-Schroeder H, Meerpohl HG. du Bois A, et al. Support Care Cancer. 1995 Sep;3(5):285-90. doi: 10.1007/BF00335303. Support Care Cancer. 1995. PMID: 8520873

7

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

8

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.

Luck HJ, Thomssen C, duBois A, Lisboa BW, Untch M, Kuhnle H, Konecny G, Janicke F, Meerpohl HG, Lindner C, Hecker D, Diergarten K. Luck HJ, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):33-6. Semin Oncol. 1996. PMID: 8629034 Clinical Trial.

9

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer.

Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K, et al. Meerpohl HG, et al. Among authors: du bois a. Semin Oncol. 1995 Dec;22(6 Suppl 15):7-12. Semin Oncol. 1995. PMID: 8643973 Clinical Trial.

10

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis.

du Bois A, Vach W, Kiechle M, Cramer-Giraud U, Meerpohl HG. du Bois A, et al. Oncology. 1996 Jun;53 Suppl 1:46-50. doi: 10.1159/000227640. Oncology. 1996. PMID: 8692551 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page